Stock listing
NASDAQ:XERS Xeris Biopharma Holdings, Inc. Stock
Home listing (NASDAQ) of Xeris Biopharma Holdings, Inc.
Follow Xeris Biopharma Holdings, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:XERS
$10.79 USD -0.35 (-3.1%)
Close on Oct 21, 2026
- Day range
- $10.77 – $11.28 USDOct 21, 2026
- Volume
- 1.68M sharesOct 21, 2026
- Market cap
- $1.97B USDAt the close on Oct 21, 2026 · price × 182.3M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:XERS · Home | $10.79 USD | -0.345 (-3.1%) | 1,676,146 | $11.14 | $11.28 | $10.77 | $11.13 | Close on Oct 21, 2026 |
| LSE:0A8E | $10.97 USD | -0.135 (-1.2%) | 13,078 | $10.90 | $11.30 | $10.79 | $11.11 | Close on Oct 21, 2026 |
| Frankfurt:2B30 | €9.77 EUR | +0.716 (+7.9%) | — | €9.77 | €9.77 | €9.77 | €9.054 | Close on Oct 21, 2026 |
Daily closes
Last 3 months, Jul 21, 2026 – Oct 21, 2026 · NASDAQ:XERS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.79 | -0.345 | -3.1% | $11.14 | $11.28 | $10.77 | 1,676,146 | |
| $11.13 | +0.18 | +1.6% | $10.99 | $11.35 | $10.96 | 2,900,510 | |
| $10.95 | +0.64 | +6.2% | $10.35 | $11.41 | $10.34 | 4,339,692 | |
| $10.31 | +0.24 | +2.4% | $10.04 | $10.33 | $9.85 | 2,288,655 | |
| $10.07 | +0.30 | +3.1% | $9.77 | $10.18 | $9.77 | 1,941,713 | |
| $9.77 | -0.43 | -4.2% | $10.08 | $10.39 | $9.73 | 2,367,071 | |
| $10.20 | -0.26 | -2.5% | $10.41 | $10.50 | $10.15 | 2,220,299 | |
| $10.46 | -0.02 | -0.2% | $10.47 | $10.55 | $10.33 | 1,328,400 | |
| $10.48 | +0.29 | +2.8% | $10.15 | $10.60 | $10.07 | 2,995,200 | |
| $10.19 | +0.08 | +0.8% | $10.10 | $10.35 | $10.00 | 1,979,100 | |
| $10.11 | +0.04 | +0.4% | $10.00 | $10.27 | $9.91 | 2,220,600 | |
| $10.07 | -0.06 | -0.6% | $10.23 | $10.33 | $9.90 | 2,404,000 | |
| $10.13 | +1.05 | +11.6% | $9.15 | $10.24 | $9.12 | 4,658,400 | |
| $9.08 | -0.17 | -1.8% | $9.34 | $9.34 | $9.04 | 1,803,600 | |
| $9.25 | -0.31 | -3.2% | $9.52 | $9.69 | $9.18 | 3,590,700 | |
| $9.56 | -0.42 | -4.2% | $9.97 | $10.07 | $9.55 | 3,753,500 | |
| $9.98 | +0.15 | +1.5% | $9.77 | $11.33 | $9.50 | 19,314,800 | |
| $9.83 | +0.73 | +8.0% | $9.05 | $10.01 | $9.00 | 4,463,300 | |
| $9.10 | +0.15 | +1.7% | $8.99 | $9.15 | $8.85 | 1,547,000 | |
| $8.95 | +0.29 | +3.3% | $8.65 | $9.00 | $8.56 | 1,359,200 | |
| $8.66 | -0.07 | -0.8% | $8.74 | $9.20 | $8.46 | 2,042,600 | |
| $8.73 | -0.07 | -0.8% | $8.90 | $8.97 | $8.64 | 1,688,300 | |
| $8.80 | +0.60 | +7.3% | $8.28 | $8.81 | $8.16 | 3,231,400 | |
| $8.20 | +0.04 | +0.5% | $8.10 | $8.25 | $7.93 | 4,709,400 | |
| $8.16 | +0.38 | +4.9% | $7.69 | $8.18 | $7.69 | 2,341,300 | |
| $7.78 | +0.29 | +3.9% | $7.50 | $7.92 | $7.50 | 2,035,000 | |
| $7.49 | -0.08 | -1.1% | $7.57 | $7.58 | $7.41 | 1,180,900 | |
| $7.57 | +0.12 | +1.6% | $7.60 | $7.69 | $7.52 | 2,006,100 | |
| $7.45 | -0.22 | -2.9% | $7.89 | $7.89 | $7.40 | 2,403,500 | |
| $7.67 | -0.04 | -0.5% | $7.80 | $7.99 | $7.63 | 1,946,000 | |
| $7.71 | -0.77 | -9.1% | $8.43 | $8.61 | $7.64 | 2,816,200 | |
| $8.48 | -0.05 | -0.6% | $8.39 | $8.52 | $8.22 | 1,354,800 | |
| $8.53 | -0.06 | -0.7% | $8.50 | $8.59 | $8.38 | 1,030,300 | |
| $8.59 | +0.01 | +0.1% | $8.64 | $8.78 | $8.42 | 1,597,900 | |
| $8.58 | +0.15 | +1.8% | $8.49 | $8.64 | $8.27 | 1,350,400 | |
| $8.43 | -0.01 | -0.1% | $8.42 | $8.62 | $8.38 | 1,144,100 | |
| $8.44 | -0.04 | -0.5% | $8.45 | $8.49 | $8.29 | 1,402,600 | |
| $8.48 | -0.12 | -1.4% | $8.62 | $8.68 | $8.37 | 1,027,300 | |
| $8.60 | -0.08 | -0.9% | $8.62 | $8.74 | $8.55 | 1,273,500 | |
| $8.68 | -0.06 | -0.7% | $8.74 | $8.89 | $8.61 | 1,504,100 | |
| $8.74 | 0.00 | 0.0% | $8.81 | $8.95 | $8.665 | 1,005,703 | |
| $8.74 | +0.04 | +0.5% | $8.66 | $8.80 | $8.539 | 870,743 | |
| $8.70 | +0.10 | +1.2% | $8.61 | $8.81 | $8.54 | 1,562,900 | |
| $8.60 | -0.18 | -2.1% | $8.91 | $8.99 | $8.56 | 2,001,200 | |
| $8.78 | -0.07 | -0.8% | $8.93 | $9.02 | $8.77 | 2,250,100 | |
| $8.85 | +0.33 | +3.9% | $8.58 | $8.88 | $8.47 | 2,142,000 | |
| $8.52 | -0.08 | -0.9% | $8.45 | $8.55 | $8.26 | 1,334,900 | |
| $8.60 | +0.27 | +3.2% | $8.33 | $8.67 | $8.25 | 1,366,200 | |
| $8.33 | -0.16 | -1.9% | $8.59 | $8.70 | $8.30 | 1,851,600 | |
| $8.49 | +0.10 | +1.2% | $8.37 | $8.52 | $8.24 | 1,728,800 | |
| $8.39 | +0.40 | +5.0% | $8.00 | $8.44 | $7.96 | 1,779,000 | |
| $7.99 | +0.06 | +0.8% | $7.96 | $8.07 | $7.80 | 1,616,100 | |
| $7.93 | +0.57 | +7.7% | $7.43 | $8.02 | $7.43 | 2,253,100 | |
| $7.36 | -0.75 | -9.2% | $7.19 | $7.44 | $7.05 | 3,724,800 | |
| $8.11 | -0.08 | -1.0% | $8.21 | $8.37 | $8.06 | 1,750,700 | |
| $8.19 | +0.06 | +0.7% | $8.13 | $8.28 | $8.04 | 1,843,600 | |
| $8.13 | +0.05 | +0.6% | $8.14 | $8.17 | $7.87 | 1,947,100 | |
| $8.08 | -0.34 | -4.0% | $8.34 | $8.41 | $7.99 | 1,623,800 | |
| $8.42 | +0.04 | +0.5% | $8.38 | $8.46 | $8.32 | 917,300 | |
| $8.38 | +0.14 | +1.7% | $8.23 | $8.49 | $8.23 | 1,194,500 | |
| $8.24 | +0.03 | +0.4% | $8.28 | $8.33 | $8.13 | 811,100 | |
| $8.21 | -0.11 | -1.3% | $8.40 | $8.47 | $8.20 | 873,400 | |
| $8.32 | -0.09 | -1.1% | $8.42 | $8.54 | $8.29 | 1,175,900 | |
| $8.41 | +0.03 | +0.4% | $8.29 | $8.44 | $8.14 | 2,191,100 | |
| $8.38 | -0.40 | -4.6% | $8.75 | $8.76 | $8.29 | 2,260,500 | |
| $8.78 | +0.18 | +2.1% | $8.60 | $8.83 | $8.60 | 1,264,200 |
- Ticker
- NASDAQ:XERS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 15, 2026
Xeris Biopharma Reinforces Leadership in Endocrinology With Data Disclosures Spanning Commercial Portfolio and Pipeline at Multiple Scientific Meetings
Latest earnings call · Aug 6, 2026
Xeris Biopharma Holdings (NASDAQ:XERS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 9, 2026
Technical Presentation (September 2026)
Technical · 24 slides
Calls
Replays
Xeris Biopharma Holdings (NASDAQ:XERS) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:30 AM ET
Watch TranscriptXeris Biopharma Holdings (NASDAQ:XERS) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:30 AM ET
Watch TranscriptXeris Biopharma Holdings (NASDAQ:XERS) Q4 2025 Earnings Call
Mon, Mar 02, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Xeris Biopharma Reinforces Leadership in Endocrinology With Data Disclosures Spanning Commercial Portfolio and Pipeline at Multiple Scientific Meetings
Oct 15, 2026
Closed $10.07 (+3.1%) on Oct 15, 2026
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $10.13 (+11.6%) on Oct 5, 2026
medmix' Drug Delivery ("Haselmeier") to Support the Development of Xeris Pharmaceuticals' XP-8121 with D-Flex(TM) Pen Injector
Sep 10, 2026
Closed $7.67 (-0.5%) on Sep 10, 2026
Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism
Sep 9, 2026
Closed $7.71 (-9.1%) on Sep 9, 2026
Xeris Announces Details for XP-8121 Program Overview Webinar
Aug 26, 2026
Closed $8.68 (-0.7%) on Aug 26, 2026
Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
Aug 6, 2026
Closed $7.93 (+7.7%) on Aug 7, 2026
Xeris Biopharma Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $7.36 (-9.2%) on Aug 6, 2026
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
Jul 23, 2026
Closed $8.41 (+0.4%) on Jul 23, 2026
Decks
Technical Presentation (September 2026)
Technical · 24 slides · Sep 9, 2026
Investor Presentation (August 2026)
Investor deck · 28 slides · August 2026
Q4 2025 Earnings Presentation
Earnings · 28 slides · Mar 2, 2026
Investor Day (June 2025)
Investor day · 58 slides · Jun 3, 2025
Xeris Biopharma Holdings, Inc. on 6ix
- News releases
- 22 in the last 12 months · 179 in all · newest Oct 15, 2026 · oldest 2019
- Calls
- 21 calls with a replay · 21 with a transcript · latest Aug 6, 2026
- Decks
- 5 decks · latest Sep 9, 2026
Where Xeris Biopharma Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:XERS · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A3C4ZC | LS Exchange | Germany | EUR |
| Tradegate:2B30 | Tradegate | Germany | EUR |
| Lang & Schwarz:A3C4ZC | Lang & Schwarz | Germany | EUR |
| Frankfurt:2B3 | Frankfurt | Germany | EUR |
| gettex:2B30 | gettex | Germany | EUR |
| LSE:0A8E | LSE | United Kingdom | USD |
| BOATS:XERS | BOATS | United States | USD |
| Dusseldorf:2B30 | Dusseldorf | Germany | EUR |
| Frankfurt:2B30 | Frankfurt | Germany | EUR |
| Munich:2B30 | Munich | Germany | EUR |
| Stuttgart:2B30 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Xeris Biopharma Holdings, Inc.